Browse Category

NASDAQ:MDLN News 9 December 2025 - 18 December 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. (Nasdaq: MDLN) is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 (down 2.49% on the day) and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing.com The timing matters: today wasn’t just “day two volatility.” Medline also officially closed its upsized IPO and confirmed that underwriters fully exercised their option for additional shares—an update that helps investors understand near-term share supply, stabilization mechanics, and how quickly the
18 December 2025
Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock—trading on the Nasdaq Global Select Market under the ticker MDLN—is having the kind of debut that makes IPO bankers briefly believe in destiny again. On Wednesday, December 17, 2025, Medline shares opened at $35 after pricing its IPO at $29, then finished the session at $41, a gain of about 41% on day one. Reuters+2Investopedia+2 On Thursday, December 18, 2025, early indications showed the stock pulling back in pre-market trading—around $39.73 as of 4:01 a.m. ET, down roughly 3% from the prior close—an unsurprising “welcome to price discovery” move after a first-day pop. StockAnalysis
18 December 2025
Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline is officially back in the public markets. On Wednesday, December 17, 2025, the Northfield, Illinois-based medical supply powerhouse begins trading on the Nasdaq Global Select Market under the ticker MDLN, following an upsized initial public offering that raised about $6.26 billion—the largest global IPO of 2025. Reuters+2Medline Newsroom+2 For Wall Street, the scale of the deal matters. For hospitals and health systems, the company’s name is already familiar: Medline sits deep inside the day-to-day plumbing of healthcare, supplying everything from surgical kits and gloves to protective apparel and logistics services. The IPO is also a major moment for the
17 December 2025
Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

NEW YORK / NORTHFIELD, Ill. — December 9, 2025 — Medical‑supply giant Medline Inc. has set the terms for a U.S. initial public offering that could raise up to $5.37 billion and value the company at as much as $55.3 billion, positioning it as the largest U.S. IPO of 2025 and one of the biggest private‑equity‑backed listings on record.Reuters+1 The Illinois‑based manufacturer and distributor of medical‑surgical supplies plans to sell 179 million shares on the Nasdaq under the ticker MDLN at a price range of $26 to $30 per share, with Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan
9 December 2025

Stock Market Today

Morgan Stanley stock price bounces after three-day slide; what to watch before Monday

Morgan Stanley stock price bounces after three-day slide; what to watch before Monday

7 February 2026
Morgan Stanley shares rose 2.34% to $179.96 Friday, snapping a three-day slide as the Dow closed above 50,000 for the first time. About 9.1 million MS shares traded hands. The rebound followed Thursday’s 2.35% drop and came amid renewed rate-cut speculation and surging AI spending. Morgan Stanley remains 6.6% below its January high.
Lam Research stock price jumps 8% as chip rally returns — what to watch next week

Lam Research stock price jumps 8% as chip rally returns — what to watch next week

7 February 2026
Lam Research shares surged 8.3% to $231.01 Friday, with after-hours trading flat. The move followed a broad rally in chip stocks, pushing the PHLX semiconductor index up 5.7% as Nvidia, AMD, and Broadcom advanced. Lam announced a $0.26 quarterly dividend and a senior executive exercised 53,925 shares. Investors await U.S. jobs and inflation data next week.
Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

7 February 2026
Goldman Sachs shares jumped 4.3% to $928.75 Friday after confirming it is working with AI startup Anthropic on internal “AI agents.” The stock’s rally helped lift the Dow above 50,000 for the first time. Delayed U.S. jobs and inflation data are due midweek and could affect rate expectations. Goldman also filed for new structured notes tied to the Russell 2000 and S&P 500.
Go toTop